IRIS
LAURIA, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.836
AS - Asia 1.600
NA - Nord America 1.576
SA - Sud America 230
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.509
SG - Singapore 869
RU - Federazione Russa 808
IT - Italia 454
CN - Cina 397
BR - Brasile 190
DE - Germania 158
VN - Vietnam 133
HK - Hong Kong 124
NL - Olanda 93
FI - Finlandia 77
UA - Ucraina 68
FR - Francia 59
CA - Canada 43
GB - Regno Unito 39
IN - India 36
IE - Irlanda 26
ZA - Sudafrica 21
AR - Argentina 18
SE - Svezia 14
CI - Costa d'Avorio 13
MX - Messico 13
PL - Polonia 11
EC - Ecuador 10
ES - Italia 8
IQ - Iraq 7
AT - Austria 6
BD - Bangladesh 5
CO - Colombia 5
KR - Corea 5
ID - Indonesia 4
JP - Giappone 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
UZ - Uzbekistan 3
BZ - Belize 2
EU - Europa 2
JM - Giamaica 2
MA - Marocco 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
CL - Cile 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
IR - Iran 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
PK - Pakistan 1
SI - Slovenia 1
TJ - Tagikistan 1
TN - Tunisia 1
TR - Turchia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 5.292
Salva come PNG Salva come JPEG
Città #
Singapore 394
Chandler 242
Moscow 189
Beijing 149
Ashburn 125
Hong Kong 124
Amsterdam 88
Napoli 86
Santa Clara 69
Millbury 59
Los Angeles 52
Jacksonville 47
Munich 45
Dallas 40
Princeton 40
Naples 38
Ho Chi Minh City 37
Nanjing 34
New York 27
Buffalo 25
Dong Ket 24
Hanoi 23
Turku 23
Helsinki 22
São Paulo 21
Wilmington 20
Des Moines 19
Pune 16
Toronto 16
Boston 15
Johannesburg 13
Redondo Beach 13
Seattle 13
Tianjin 13
Hefei 12
Milan 11
Ottawa 11
Montreal 10
The Dalles 10
Lawrence 9
Shenyang 9
Warsaw 9
Brooklyn 8
Chicago 8
Falkenstein 8
Falls Church 8
Frankfurt am Main 8
Nanchang 8
Orem 8
Poplar 8
Rome 8
Stockholm 8
Belo Horizonte 7
Jiaxing 7
London 7
Mexico City 7
Nuremberg 7
Redwood City 7
Rozzano 7
Ann Arbor 6
Casoria 6
Denver 6
Phoenix 6
Porto Alegre 6
Rio de Janeiro 6
Borgomanero 5
Changsha 5
Charlotte 5
Guayaquil 5
Haiphong 5
Hangzhou 5
Jinan 5
Leawood 5
Manchester 5
Salerno 5
Shanghai 5
Atlanta 4
Augusta 4
Bologna 4
Brasília 4
Chennai 4
Dearborn 4
Dublin 4
Fairfield 4
Hải Dương 4
Menfi 4
Mumbai 4
New Delhi 4
Ninh Bình 4
Quito 4
San Francisco 4
San Mateo 4
Taizhou 4
Tokyo 4
Washington 4
Araraquara 3
Battipaglia 3
Contagem 3
Duncan 3
Elk Grove Village 3
Totale 2.553
Salva come PNG Salva come JPEG
Nome #
null 223
Manuale di Oncologia Clinica 187
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 152
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 149
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 144
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 131
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 121
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 120
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 118
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 116
Tumor characteristics and prognosis in familial breast cancer 113
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour 113
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 113
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 113
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 111
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis 109
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 109
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 108
Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma 106
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues 105
Chlorambucil, Vincristine and Cytarabine (COA) treatment of low grade lymphomas 104
Core curriculum. Oncologia clinica 104
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study 102
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 101
Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer 100
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 99
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 98
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 97
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 96
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 96
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. 96
Advanced and Locally unresectable gastric carcinoma: five years of survival with good quality of life. 95
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 95
Changing presentation in non Hodgkin lymphoma". 94
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 93
CAVBP-DEP Altemative Chemotherapy for the treatment of intermediate and high grade non Hodgkin lymphoma: final results of a pilot study. 93
Tailored therapy for aggressive non-Hodgkin’s lymphoma: results of a phase II study with a long-term follow-up. 92
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 92
Capitolo 15: i Tumori Ginecologici 92
Core curriculum. Oncologia clinica 90
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 88
Bone involvement by adenocarcinoma of the uterine cervix: a rare entity 87
Comparison of Tropisetron (ICS 205-930) with alizapride plus dexamethasone in the prevention of emesis induced by repeated cisplatin administration. 85
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 84
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. 81
Maintenance therapy with recombinant Interferon Alpha-2b (IFN) in prognostically in prognastically unfavourable aggressive non-Hodgkin’s lymphomas. 81
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial. 76
'Primary Bone Lymphoma". 73
null 67
Salvage chemotherapy for non Hodgldn's lymphoma of unfavorable histology with a combination of CCNU and Vinblastine. 67
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. 59
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety 45
Totale 5.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 26 26 8 34 3 32 29
2021/2022342 8 1 7 5 3 13 6 9 26 40 111 113
2022/2023523 57 65 18 42 57 54 3 39 74 92 16 6
2023/2024284 11 52 32 22 17 47 5 29 4 5 48 12
2024/20251.563 63 42 13 20 66 80 137 117 89 152 669 115
2025/20261.724 317 171 341 317 544 34 0 0 0 0 0 0
Totale 5.383